PYNOCARE (Procyanidin + Ascorbic Acid + Betacarotene + d-Alpha-Tocopheryl Acetate) is the first and only oral medicine that is clinically proven to reduce Melasma or dark spots formation in just 8 weeks. Unlike creams, lotions and gels, it has MSCC or Melasma Skin Clear Complexion Complex formulation that deeply penetrates the inner layers of the skin to help normalize melanin levels, thus minimizing the appearance of dark spots in a short time.
PYNOCARE (Procyanidin + Ascorbic Acid + Betacarotene + d-Alpha-Tocopheryl Acetate) since 2005 in the market and is dermatologist-recommended. Number of women who have tried Pynocare is close to 100k.
If symptoms persist, consult your doctor.
Approved as OTC drug by FDA
Pynocare ( Procyanidin + Ascorbic Acid + Betacarotene + d-Alpha + Tocopheryl Acetate) proven effective thus FDA has categorized it as an OTC drug that can treat melasma. FDA Registration Number: DR-XY29636.
Clinically Tested in the Philippines
“In this 8-week trial period, oral procyanidin + vitamins A,C, E proved to be safe and effective among Filipino women with epidermal melasma.”
Excerpt from a randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E on melasma among Filipino women.
Evangeline B. Handog, MD, FPDS, FAAD
Ma. Dulce Amor Vivan L. Feliciano, MD, 2009
Clinically Tested in Malaysia
“There was significant improvement in the degree of lightening of the skin in the treatment group following the one month period of treatment when compared to the placebo group for which the changes was not significant.”
Excerpt from The Efficacy and Safety of French Maritime Pine Bark Extract in the Form of MSCC Complex Actisome on Melasma.
Shahrir MS et al, J of Int. Med Dec 2004.
Clinically Tested in Thailand
“22 healthy women aged 20-60, with melasma not having used any treatments for the past 2 months took oral supplement every day during all the study period of 12 weeks, twice daily after meal; 1 capsule/time, in the morning and in the evening with at least 6 hours between two capsules. Efficacy rate of 85% in the reduction of the size and intensity of melasma lesions.”
Excerpt from Evaluation of the Efficacy of an anti-melasma oral supplement by self- assessment questionnaires. Reference Product: Pynocare (containing MSCC Complex- Melasma Skin Clear Complexion Complex)
Dr. Fabrice Perin, Spincontrol, Thailand July 2004.
Pynocare (Procyanidin + Ascorbic Acid + Betacarotene + d-Alpha-Tocopheryl Acetate) has proprietary Melasma Skin Clear Complex (MSCC) formulation - a combination of powerful antioxidants that targets dark spots at its root cause and other damaging free radicals that causes overproduction of melanin.
About the Company
PYNOCARE (Procyanidin + Ascorbic Acid + Betacarotene + d-Alpha-Tocopheryl Acetate) is made by Mega Lifesciences Pty. Ltd. (MegaWeCare).
Mega Lifesciences Pty. Ltd. is one of the leading players in the health and wellness business with presence in 29 developing countries. We are engaged in developing, manufacturing, marketing and selling our own brand of nutraceuticals and pharmaceuticals under our marketing arm Mega We Care. Currently, we have offices in 18 countries operating in Asia, Africa, Middle East, South America and Europe.
In 2001, Mega We Care introduced its products to the Philippines, providing branded generic drugs in the therapeutic areas of dermatology, gastroenterology, ob-gyn and orthopedics. It offers complimentary medicines under general, men’s and women’s health and beauty categories. We belong to the Top 50 Pharmaceutical Companies in the country as of 2013 IMS report.
Precautions / Contraindications
Pynocare 40 Actisome is indicated for treatment of melasma by reducing the size and intensity of irregular pigmentation. It improves skin smoothness and elasticity while protecting it from the harmful effects of environmental stress.
Pynocare is not to be used by persons with known hypersensitivity to any of the components. Not recommended for 18 years old below, during pregnancy and lactation unless with medical advice from a physician.